Continuous vasopressin replacement in diabetes insipidus

Area of Science:

• Pediatric Endocrinology
• Nephrology
• Critical Care Medicine

Background:

• Severe brain injury is a known cause of central diabetes insipidus.
• Diabetes insipidus in children presents with polyuria, hypernatremia, and dilute urine.
• Management of pediatric diabetes insipidus requires careful fluid and hormone replacement.

Purpose of the Study:

• To evaluate the efficacy and safety of continuous intravenous vasopressin combined with crystalloid replacement in children with diabetes insipidus secondary to severe brain injury.

Main Methods:

• Five pediatric patients with diabetes insipidus post-brain injury were treated.
• Continuous intravenous infusion of aqueous vasopressin was administered.
• Appropriate crystalloid solutions were used for fluid and electrolyte replacement.

Main Results:

• All five patients showed safe and effective correction of polyuria.
• Hypernatremia and decreased urine osmolality were resolved in all participants.
• Treatment success was achieved within 8 to 28 hours.

Conclusions:

• Continuous intravenous vasopressin and crystalloid replacement is a safe and effective treatment for pediatric diabetes insipidus.
• This therapeutic approach rapidly normalizes fluid and electrolyte balance in affected children.
• Prompt management is crucial for children with severe brain injury and subsequent diabetes insipidus.